Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

8.9K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD4<sup>+</sup> T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

Science translational medicine·2026
Same author

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Factors That Influence Blood Pressure Changes With the Use of Sodium-Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes.

Pharmacotherapy·2026
Same author

Neurolymphomatosis: A Comprehensive Review of Clinical and Imaging Features.

Radiology. Imaging cancer·2026
Same author

Development and expert refinement of a stratified framework for progression independent of relapse activity (PIRA) in multiple sclerosis.

Clinical neurology and neurosurgery·2026
Same author

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026

Related Experiment Video

Updated: Dec 30, 2025

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

24.0K

MRI differences between MOG antibody disease and AQP4 NMOSD.

Sara Salama1, Majid Khan2, Amirali Shanechi2

  • 1Department of Neurology and Psychiatry, University of Alexandria, Alexandria, Egypt/Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 16, 2020
PubMed
Summary

Distinguishing MOG antibody disease from AQP4 antibody NMOSD is crucial. Orbital MRI findings are more common in MOG antibody disease, while spinal cord lesions suggest AQP4 antibody NMOSD.

Keywords:
AQP4 antibodyMOG antibodyNMOSDmagnetic resonance imaging

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.7K

Related Experiment Videos

Last Updated: Dec 30, 2025

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

24.0K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.7K

Area of Science:

  • Neurology
  • Immunology
  • Radiology

Background:

  • Neuromyelitis optica spectrum disorders (NMOSD) encompass distinct MOG antibody and AQP4 antibody seropositive subtypes.
  • These subtypes present with similar clinical symptoms, necessitating advanced diagnostic tools.
  • Magnetic Resonance Imaging (MRI) plays a key role in differentiating MOG antibody disease from AQP4 antibody NMOSD.

Purpose of the Study:

  • To identify and characterize neuroradiological distinctions between MOG antibody disease and AQP4 antibody NMOSD.
  • To establish MRI-based criteria for distinguishing these two NMOSD entities.
  • To aid in early and accurate diagnosis of MOG antibody disease versus AQP4 antibody NMOSD.

Main Methods:

  • Retrospective analysis of MRI scans from 26 MOG antibody-positive and 25 AQP4 antibody-positive patients.
  • Comparative assessment of brain, spinal cord, and orbital MRI features.
  • Evaluation of lesion patterns and locations specific to each antibody subtype.

Main Results:

  • Orbital MRI abnormalities were predominant in the MOG antibody cohort.
  • Spinal cord lesions were more frequently observed in the AQP4 antibody cohort.
  • Distinct brain MRI findings included cortical/juxtacortical white matter involvement in MOG antibody disease and rare area postrema involvement.

Conclusions:

  • Cortical gray/juxtacortical white matter lesions on brain MRI are potential indicators for distinguishing MOG antibody disease from AQP4-positive NMOSD.
  • These MRI findings can assist in differentiating the two conditions, even at initial presentation.
  • Accurate differentiation is vital for appropriate treatment strategies in NMOSD management.